NO20071221L - Systemer og fremgangsmater for protein produksjon. - Google Patents

Systemer og fremgangsmater for protein produksjon.

Info

Publication number
NO20071221L
NO20071221L NO20071221A NO20071221A NO20071221L NO 20071221 L NO20071221 L NO 20071221L NO 20071221 A NO20071221 A NO 20071221A NO 20071221 A NO20071221 A NO 20071221A NO 20071221 L NO20071221 L NO 20071221L
Authority
NO
Norway
Prior art keywords
cells
protein
interest
systems
polypeptide
Prior art date
Application number
NO20071221A
Other languages
English (en)
Norwegian (no)
Inventor
Yijie Gao
Nicole M Piche
Mei Geng
Stephen H Herrmann
Xiaotian Zhong
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20071221L publication Critical patent/NO20071221L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20071221A 2004-09-02 2007-03-06 Systemer og fremgangsmater for protein produksjon. NO20071221L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60643904P 2004-09-02 2004-09-02
PCT/US2005/031081 WO2006028889A2 (en) 2004-09-02 2005-09-01 Systems and methods for protein production

Publications (1)

Publication Number Publication Date
NO20071221L true NO20071221L (no) 2007-03-30

Family

ID=36036848

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071221A NO20071221L (no) 2004-09-02 2007-03-06 Systemer og fremgangsmater for protein produksjon.

Country Status (16)

Country Link
US (3) US7514237B2 (pt)
EP (2) EP2316955B1 (pt)
JP (2) JP2008511335A (pt)
KR (1) KR20070053732A (pt)
CN (1) CN101048509A (pt)
AU (1) AU2005282746A1 (pt)
BR (1) BRPI0514870A (pt)
CA (1) CA2577073C (pt)
CR (1) CR8927A (pt)
EC (1) ECSP077295A (pt)
ES (2) ES2649862T3 (pt)
IL (1) IL181278A0 (pt)
MX (1) MX2007002379A (pt)
NO (1) NO20071221L (pt)
RU (1) RU2007106442A (pt)
WO (1) WO2006028889A2 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5548932B2 (ja) * 2006-09-25 2014-07-16 国立大学法人大阪大学 Ａｔｆ４および／またはｇａｄｄ３４を利用した蛋白質高生産方法
EP2297331B1 (en) * 2008-05-28 2015-03-25 Bayer HealthCare, LLC Methods and compositions for production of recombinant protein in hbx-expressing mammalian cells
CA2726804C (en) 2008-06-02 2021-12-28 Dana-Farber Cancer Institute, Inc. Xbp1, cd138, and cs1 peptides
GB0902180D0 (en) 2009-02-10 2009-03-25 Ucb Pharma Sa Method for producing protein
US9315565B2 (en) 2009-02-10 2016-04-19 Ucb Pharma, S.A. Method for producing protein
WO2010151827A1 (en) * 2009-06-25 2010-12-29 Bayer Healthcare Llc X-box binding proteins (xbp-1) variants and methods of using the same
TW201823460A (zh) 2012-05-29 2018-07-01 美商再生元醫藥公司 生產細胞株增強子
CL2015003242A1 (es) 2015-11-04 2016-10-14 Univ Chile Virus aav/upr-plus, proteína de fusión upr-plus, método de tratamiento genético y su uso en el tratamiento enfermedades neurodegenerativas, tales como las enfermedades de parkinson y huntington, entre otras.
WO2019010551A1 (pt) * 2017-07-10 2019-01-17 Instituto De Biologia Molecular Do Paraná - Ibmp Plataforma genética para superexpressão heteróloga associada à seleção de células altamente produtoras de proteínas
CN107858378B (zh) * 2017-11-20 2020-11-10 中国科学院生物物理研究所 衰老细胞模型及其制备方法
CN110093361B (zh) * 2019-04-17 2023-05-09 拜澳泰克(沈阳)生物医学集团有限公司 一种增强基因表达的增强子多肽及其应用
KR20230078719A (ko) 2020-09-28 2023-06-02 베스타론 코포레이션 해충 방제용 뮤-디구에톡신-Dc1a 변이형 폴리펩타이드
CN116670282A (zh) * 2020-12-22 2023-08-29 豪夫迈·罗氏有限公司 靶向xbp1的寡核苷酸
US20240374761A1 (en) 2021-05-05 2024-11-14 Radius Pharmaceuticals, Inc. Animal model having homologous recombination of mouse pth1 receptor
WO2023122805A1 (en) 2021-12-20 2023-06-29 Vestaron Corporation Sorbitol driven selection pressure method
EP4413121A4 (en) 2022-06-09 2025-06-04 CHO Plus Inc. Cell hybrids as host cells for high efficiency production of gene therapy vectors and viral vaccines
WO2024026406A2 (en) 2022-07-29 2024-02-01 Vestaron Corporation Next Generation ACTX Peptides
WO2025024776A2 (en) * 2023-07-27 2025-01-30 Duke University Compositions comprising xbp1 fragments and methods of use in gene therapy
WO2026015884A1 (en) * 2024-07-11 2026-01-15 Helix Nanotechnologies Inc Compositions comprising ire-1 binding sequences and uses thereof
CN120888609B (zh) * 2025-10-10 2025-12-23 汇智和源生物技术(苏州)有限公司 一种瞬时高效表达人源slc转运体oatp1b3的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063630A (en) 1991-11-05 2000-05-16 Transkaryotic Therapies, Inc. Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
AU745960C (en) 1997-11-18 2003-09-18 Pioneer Hi-Bred International, Inc. A novel method for the integration of foreign DNA into eukaryoticgenomes
AU4903099A (en) 1998-07-01 2000-01-24 Austrian Nordic Biotherapeutics Ag Targeted integration into chromosomes using retroviral vectors
JP2001054391A (ja) * 1998-11-13 2001-02-27 Hsp Kenkyusho:Kk 小胞体ストレス転写因子
WO2001072783A2 (en) 2000-03-24 2001-10-04 Genencor International, Inc. Production of secreted proteins by recombinant eukaryotic cells
WO2003089622A2 (en) 2002-04-22 2003-10-30 University Of Michigan Novel genes, compositions, and methods for modulating the unfolded protein response
JP4446057B2 (ja) * 2002-08-28 2010-04-07 独立行政法人理化学研究所 生体刺激存在下でのｍＲＮＡのフレームシフトを利用した蛋白質の発現方法
JP2007500016A (ja) * 2003-06-11 2007-01-11 バイオジェン・アイデック・エムエイ・インコーポレイテッド 培養においてタンパク質生成を増大させるための方法

Also Published As

Publication number Publication date
US8173394B2 (en) 2012-05-08
US7514237B2 (en) 2009-04-07
BRPI0514870A (pt) 2008-06-24
CA2577073C (en) 2016-10-11
AU2005282746A1 (en) 2006-03-16
WO2006028889A2 (en) 2006-03-16
US20060053502A1 (en) 2006-03-09
ES2649862T3 (es) 2018-01-16
ECSP077295A (es) 2007-04-26
RU2007106442A (ru) 2008-10-10
US20120322104A1 (en) 2012-12-20
EP2316955A1 (en) 2011-05-04
CN101048509A (zh) 2007-10-03
US20090221035A1 (en) 2009-09-03
JP5508460B2 (ja) 2014-05-28
EP1784490B1 (en) 2017-11-01
CA2577073A1 (en) 2006-03-16
MX2007002379A (es) 2007-04-23
KR20070053732A (ko) 2007-05-25
JP2008511335A (ja) 2008-04-17
ES2653843T3 (es) 2018-02-09
CR8927A (es) 2007-08-28
IL181278A0 (en) 2007-07-04
EP2316955B1 (en) 2017-10-04
JP2012161318A (ja) 2012-08-30
EP1784490A2 (en) 2007-05-16
WO2006028889A3 (en) 2006-10-05

Similar Documents

Publication Publication Date Title
Madio et al. Sea anemone toxins: A structural overview
ECSP077295A (es) Sistemas y metodos para la produccion de proteinas
Zheng et al. Isolation of novel ACE-inhibitory and antioxidant peptides from quinoa bran albumin assisted with an in silico approach: Characterization, in vivo antihypertension, and molecular docking
Gomez et al. In silico and in vitro assessment of portuguese oyster (Crassostrea angulata) proteins as precursor of bioactive peptides
Monastyrnaya et al. Kunitz-type peptide HCRG21 from the sea anemone Heteractis crispa is a full antagonist of the TRPV1 receptor
Fan et al. Spent hen protein hydrolysate with good gastrointestinal stability and permeability in caco-2 cells shows antihypertensive activity in SHR
Sangiorgio et al. Preparation, characterization and in vitro stability of a novel ACE-inhibitory peptide from soybean protein
Fry et al. Tentacles of venom: toxic protein convergence in the Kingdom Animalia
Yee et al. Snake venom metalloproteinases and their peptide inhibitors from Myanmar Russell’s viper venom
Nwachukwu et al. Thermoase-derived flaxseed protein hydrolysates and membrane ultrafiltration peptide fractions have systolic blood pressure-lowering effects in spontaneously hypertensive rats
DK2327719T3 (da) Hybrid- og tandemekspression af neisseria-proteiner
Martínez-Alarcón et al. Expression of lectins in heterologous systems
Rheault et al. Molecular cloning, phylogeny and localization of AgNHA1: the first Na+/H+ antiporter (NHA) from a metazoan, Anopheles gambiae
Hayes et al. Generation of bioactive peptides from Porphyridium sp. and assessment of their potential for use in the prevention of hypertension, inflammation and pain
BR0107474A (pt) Preparação de proteìnas e permuteìnas desalergenizadas
Samtiya et al. Production, purification, and potential health applications of edible seeds’ bioactive peptides: A concise review
Walker et al. Missiles of mass disruption: composition and glandular origin of venom used as a projectile defensive weapon by the assassin bug Platymeris rhadamanthus
Ventura et al. Glycoproteins involved in sea urchin temporary adhesion
Monastyrnaya et al. The sea anemone neurotoxins modulating sodium channels: an insight at structure and functional activity after four decades of investigation
Khamtorn et al. De novo transcriptome analysis of the venom of Latrodectus geometricus with the discovery of an insect-selective Na channel modulator
Ayala-Niño et al. Novel bioactive peptides sequences released by in vitro digestion of proteins isolated from Amaranthus hypochondriacus
Ribeiro et al. Are vicilins another major class of legume lectins?
Yao et al. BmP09, a “long chain” scorpion peptide blocker of BK channels
Liu et al. Uncovering a Latent Bioactive Interleukin‐6 Glycoform
DE69906108D1 (de) Peptid-derivat

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application